(Q43868527)

27 November 2017

Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture (English)

1 reference

27 November 2017

0 references

1 reference

1 reference

Wenbo Zhou

1

1 reference

27 November 2017

Jerome Schaack

series ordinal

2

1 reference

27 November 2017

W Michael Zawada

series ordinal

3

1 reference

27 November 2017

Curt R Freed

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

926

1 reference

27 November 2017

1-2

1 reference

27 November 2017

42-50

1 reference

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

New animal models for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Neuropathology in movement disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Parkinson's pathology in a fly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

alpha-synuclein promotes mitochondrial deficit and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Alpha-synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Neuropathology in mice expressing human alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Synphilin-1 is present in Lewy bodies in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Growth Factors Rescue Embryonic Dopamine Neurons from Programmed Cell Death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903292-9

10.1016/S0006-8993(01)03292-9

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference